Purdue University holds the rights to a new test for highly-pathogenic avian influenza that can be used by farmers.
Avian flu has so far claimed more than 14 million Canadian birds and 131 million in the United States since February 2022.
The researchers have developed a paper-based assay test that requires minimum training and only a water bath to deliver the results on the presence of the virus.
Farmers and those who manage commercial poultry operations can use an oral or nasal swab and transfer the sample to the paper-based devices that can be more easily read than current diagnostic methodologies, the Purdue research team said.
The technology is owned by the Purdue Research Foundation and has been exclusively licensed to the start-up Krishi, a Purdue Strategic Ventures portfolio company.
The technology is flexible enough to ultimately be used to test other potential candidates for HPAI transmission, including cattle, humans and other mammals, the release said.
